INTRODUCTION
Papillary thyroid carcinoma (PTC) is most common variety of differentiated thyroid carcinoma (DTC). This disease is curable in low risk group with proper management having excellent prognosis. Bone metastases from DTC had been ranged from 2-13 % cases in different studies. After the age of 40 years, PTC showed 10% distant metastases.
Most common sites of metastases from PTC are cervical lymphnodes and they rarely metastasize to distant regions like bone. PTC patients with history of metastases showed bony metastases in 1.4-7%. Although, PTC patients without metastases showed 10 years survival in >90% cases, poor prognosis was found in patients with bony metastases in previous studies. About 13-21% patients with bony metastases showed 10 years survival (1) . Early diagnosis and staging of the tumor, 131 I avidity, and presence of distant metastases at diagnosis and age of the patient affect the treatment outcome of these types of patients (2, 3) . Here, a rare case of elderly female patient with PTC having huge bony metastases in right hip bone and frontal bone is reported.
CASE REPORT
PTC without metastases is most curable cancer among all DTC. However, it rarely metastasizes to bone and in those cases prognosis is poor. A 55 years old female has presented with history of painless swelling on frontal region of skull for one year and 'doughnut' lesion of frontal bone and a big lesion with 'hot' and 'cold' areas in right pelvic bone suggesting metastatic lesions. Two metastatic bony lesions from PTC were found on sternum in female patients in another study. These patients had sternectomy followed by radioiodine therapy and were in remission of disease (7). Another study Previous data of different studies showed that osseous metastases and non-radioiodine avid tumor had poor prognosis with decreased cancer specific survival (6) . Surgical removal of distant metastatic masses and followed by radioiodine therapy are recommended by British Thyroid Association guidelines, 2014 (8) . These measures improve the quality of life of patient and are associated good prognosis. In our case, patient only received EBRT and pain palliation presently. Expert surgeons of Bangabandhu Sheikh Mujib Medical University have agreed to excise the masses, which would be followed by RAI therapy.
CONCLUSION
PTC with metastatic multiple bony lesions is a very rare condition. Bony metastases of PTC may present in advanced stages may be due to initial painless condition. Prognosis is better in early detected cases when lesions are confined to bone marrow or bone.
Morbidity is higher and survival is poor in advanced cases. Ultrasonography is a good supportive tool for assessment of bony metastases from thyroid cancer in initial stage and in subsequent follow up. It gives information about the size and extension of the mass.
This case of PTC with huge bony lesions could not be treated by radioiodine therapy yet due to intracranial extension of skull mass. Surgical excision of masses followed by radioiodine therapy has been planned for this patient.
